RecruitingCoronary Artery Disease
Prevail Global Study
Eligible age
18+ yrs
Accepts
All genders
Locations
28 states
Healthy volunteers
No
See if you qualify for this study
Answer a few quick questions about your location and health. Takes about a minute.
About this study
The purpose of the study is to evaluate the clinical safety and efficacy of the Prevail DCB.
Sponsor: Medtronic Vascular
You may qualify if…
- ✓ ≥ 18 years
- ✓ Negative pregnancy test
- ✓ Stable or unstable angina, positive functional test, or stable NSTEMI
- ✓ Life expectancy \>1 year
- ✓ Willing and able to cooperate with study procedures and required follow up evaluations
You may not qualify if…
- ✕ Known hypersensitivity or contraindication to antiplatelet medications or a sensitivity to contrast media which cannot be adequately pre-medicated
- ✕ History of an allergic reaction or significant sensitivity to paclitaxel or any other analogue or derivative
- ✕ Platelet count \< 100,000 cells/mm³ or \> 700,000 cells/mm³, or a white blood cell (WBC) count \< 3,000 cells/mm³
- ✕ Renal insufficiency (or failure)
- ✕ Acute MI
- ✕ Previous PCI of the target vessel within 6 months prior to the procedure
- ✕ Planned PCI of any vessel within 72 hours post-index procedure and/or planned PCI of the target vessel within 12 months post-procedure
- ✕ History of a stroke or transient ischemic attack (TIA)
Where it's recruiting
Alabama
Birmingham · Huntsville
Arizona
Tucson
Arkansas
Little Rock
California
Stanford
Colorado
Loveland
District of Columbia
Washington D.C.
Florida
Clearwater · Gainesville · Miami
Georgia
Atlanta
Illinois
Chicago · Naperville
Indiana
Fort Wayne
Kansas
Kansas City · Overland Park · Wichita
Kentucky
Edgewood · Louisville
Source: ClinicalTrials.gov · NCT06535854 · last updated 2026-10-21